Colorectal Cancer

  • Pan-tumor biomarkers are key to some of today’s most remarkable cancer breakthroughs. One such biomarker is microsatellite instability (MSI), which plays an important role in immunotherapy treatment for advanced colorectal cancer patients. In the last four years, for example, the FDA approved two …

    Continue Reading

  • Completing the Puzzle for Colorectal Cancer

    Each person and each cancer is unique, and the goal of precision medicine is to uncover this individuality. For colorectal cancer (CRC), we have discovered a few important pieces of the puzzle, but the entire picture is incomplete. There is an urgent need to discover more specific predictive markers of CRC that can …

    Continue Reading